{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "6752950", "DateCompleted": {"Year": "1982", "Month": "12", "Day": "21"}, "DateRevised": {"Year": "2019", "Month": "05", "Day": "01"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0027-8424", "JournalIssue": {"Volume": "79", "Issue": "18", "PubDate": {"Year": "1982", "Month": "Sep"}}, "Title": "Proceedings of the National Academy of Sciences of the United States of America", "ISOAbbreviation": "Proc Natl Acad Sci U S A"}, "ArticleTitle": "Inhibition of the mutagenicity of bay-region diol epoxides of polycyclic aromatic hydrocarbons by naturally occurring plant phenols: exceptional activity of ellagic acid.", "Pagination": {"StartPage": "5513", "EndPage": "5517", "MedlinePgn": "5513-7"}, "Abstract": {"AbstractText": ["Ferulic, caffeic, chlorogenic, and ellagic acids, four naturally occurring plant phenols, inhibit the mutagenicity and cytotoxicity of (+/-)-7beta,8alpha-dihydroxy-9alpha, 10alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene (B[a]P 7,8-diol-9,10-epoxide-2), the only known ultimate carcinogenic metabolite of benzo[a]pyrene. The mutagenicity of 0.05 nmol of B[a]P 7,8-diol-9,10-epoxide-2 in strain TA100 of Salmonella typhimurium is inhibited 50% by incubation of the bacteria and the diol epoxide with 150 nmol of ferulic acid, 75 nmol of caffeic acid, 50 nmol of chlorogenic acid or, most strikingly, 1 nmol of ellagic acid in the 0.5-ml incubation mixture. A 3-nmol dose of ellagic acid inhibits mutation induction by 90%. Ellagic acid is also a potent antagonist of B[a]P 7,8-diol-9,10-epoxide-2 in Chinese hamster V79 cells. Mutations to 8-azaguanine resistance induced by 0.2 muM diol epoxide are reduced by 50% when tissue culture media also contains 2 muM ellagic acid. Similar to results obtained with the bacteria, ferulic, caffeic, and chlorogenic acids are approximately two orders of magnitude less active than ellagic acid in the mammalian cell assay. The antimutagenic effects of the plant phenols result from their direct interaction with B[a]P 7,8-diol-9,10-epoxide-2, because a concentration-dependent increase in the rate of diol epoxide disappearance in cell-free solutions of 1:9 dioxane/water, pH 7.0, is observed with all four phenols. In parallel with the mutagenicity studies, ellagic acid is 80-300 times more effective than the other phenols in accelerating the disappearance of B[a]P 7,8-diol-9,10-epoxide-2. Ellagic acid at 10 muM increases the disappearance of B[a]P 7,8-diol-9,10-epoxide-2 by approximately 20-fold relative to the spontaneous and hydronium ion-catalyzed hydrolysis of the diol epoxide at pH 7.0. Ellagic acid is a highly potent inhibitor of the mutagenic activity of bay-region diol epoxides of benzo[a]pyrene, dibenzo[a,h]pyrene, and dibenzo[a,i]pyrene, but higher concentrations of ellagic acid are needed to inhibit the mutagenic activity of the chemically less reactive bay-region diol epoxides of benz[a]anthracene, chrysene, and benzo[c]phenanthrene. These studies demonstrate that ellagic acid is a potent antagonist of the adverse biological effects of the ultimate carcinogenic metabolites of several polycyclic aromatic hydrocarbons and suggest that this naturally occurring plant phenol, normally ingested by humans, may inhibit the carcinogenicity of polycyclic aromatic hydrocarbons."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [], "LastName": "Wood", "ForeName": "A W", "Initials": "AW"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Huang", "ForeName": "M T", "Initials": "MT"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Chang", "ForeName": "R L", "Initials": "RL"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Newmark", "ForeName": "H L", "Initials": "HL"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Lehr", "ForeName": "R E", "Initials": "RE"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Yagi", "ForeName": "H", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Sayer", "ForeName": "J M", "Initials": "JM"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Jerina", "ForeName": "D M", "Initials": "DM"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Conney", "ForeName": "A H", "Initials": "AH"}], "PublicationTypeList": ["Comparative Study", "Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Proc Natl Acad Sci U S A", "NlmUniqueID": "7505876", "ISSNLinking": "0027-8424"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Epoxy Compounds"}, {"RegistryNumber": "0", "NameOfSubstance": "Ethers, Cyclic"}, {"RegistryNumber": "0", "NameOfSubstance": "Mutagens"}, {"RegistryNumber": "0", "NameOfSubstance": "Phenols"}, {"RegistryNumber": "0", "NameOfSubstance": "Polycyclic Compounds"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Cricetinae"}, {"QualifierName": [], "DescriptorName": "Cricetulus"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Epoxy Compounds"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ethers, Cyclic"}, {"QualifierName": [], "DescriptorName": "Lung"}, {"QualifierName": [], "DescriptorName": "Mutagenicity Tests"}, {"QualifierName": [], "DescriptorName": "Mutagens"}, {"QualifierName": [], "DescriptorName": "Mutation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Phenols"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Polycyclic Compounds"}, {"QualifierName": ["drug effects"], "DescriptorName": "Salmonella typhimurium"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "J Am Chem Soc. 1975 Nov 12;97(23):6881-3", "ArticleIdList": ["1184887"]}, {"Citation": "J Am Chem Soc. 1977 Mar 2;99(5):1604-11", "ArticleIdList": ["839009"]}, {"Citation": "Proc Natl Acad Sci U S A. 1977 Jul;74(7):2746-50", "ArticleIdList": ["331315"]}, {"Citation": "Mutat Res. 1981 Nov;90(3):201-12", "ArticleIdList": ["7035936"]}, {"Citation": "Cancer Lett. 1981 Dec;14(3):251-60", "ArticleIdList": ["7199376"]}, {"Citation": "Proc Natl Acad Sci U S A. 1982 Sep;79(17):5122-6", "ArticleIdList": ["6813854"]}, {"Citation": "J Lab Clin Med. 1964 Sep;64:385-98", "ArticleIdList": ["14215456"]}, {"Citation": "Biochemistry. 1964 Sep;3:1308-14", "ArticleIdList": ["14229674"]}, {"Citation": "Blood. 1966 Jan;27(1):93-102", "ArticleIdList": ["5902867"]}, {"Citation": "Thromb Diath Haemorrh. 1967 Feb 28;17(1-2):165-75", "ArticleIdList": ["5584949"]}, {"Citation": "J Pharm Sci. 1968 Oct;57(10):1728-32", "ArticleIdList": ["5693427"]}, {"Citation": "J Am Chem Soc. 1972 Feb 9;94(3):939-45", "ArticleIdList": ["5061140"]}, {"Citation": "J Am Chem Soc. 1974 Feb 20;96(4):1224-5", "ArticleIdList": ["4816471"]}, {"Citation": "Cancer Res. 1978 Feb;38(2):354-8", "ArticleIdList": ["620406"]}, {"Citation": "Cancer Lett. 1978 Oct;5(4):191-7", "ArticleIdList": ["688201"]}, {"Citation": "Cancer Res. 1980 Aug;40(8 Pt 1):2820-3", "ArticleIdList": ["7388831"]}, {"Citation": "Cancer Res. 1981 Jul;41(7):2589-97", "ArticleIdList": ["7018665"]}, {"Citation": "Biochemistry. 1981 Dec 8;20(25):7258-66", "ArticleIdList": ["6797471"]}], "ReferenceList": []}], "History": [{"Year": "1982", "Month": "9", "Day": "1"}, {"Year": "1982", "Month": "9", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1982", "Month": "9", "Day": "1", "Hour": "0", "Minute": "0"}, {"Year": "1983", "Month": "3", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["6752950", "PMC346934", "10.1073/pnas.79.18.5513"]}}]}